Are estrogen receptors cytoplasmic or nuclear? Some immunocytochemical and biochemical studies.
The subcellular localization of estradiol receptor (ER) has been examined using various experimental approaches. Immunocytochemical studies using the monoclonal antibody JS 34/32, raised against calf uterine cytosolic ER, yielded only equivocal results. In general, cells and tissues pretreated with estradiol showed positive immunostaining in the nuclei whereas those not exposed to the steroid did not show any staining. Nuclear translocation of ER was examined in intact MCF-7 cells using compounds which are known to influence receptor activation. When MCF-7 cells were exposed to molybdate (20 mM), nuclear translocation was completely inhibited while dithiothreitol (20 mM), dibutyryl cAMP (1 microM) and dibutyryl cGMP (1 microM) increased the translocation 2-3-fold. Phenol red, at the range of concentrations generally used in tissue culture media, also increased translocation. The physiological validity of such translocation was examined using cellular progesterone receptor (PR) synthesis as a specific parameter. When MCF-7 cells were grown in media containing phenol red for 48 h, the PR synthesis increased significantly. We further examined whether cytoskeletal proteins are involved in the translocation of ER. Colchicine, an inhibitor of microtubule assembly, inhibited translocation of ER in MCF-7 cells at 1-10 microM. PR synthesis was also inhibited by colchicine in a dose-dependent manner. It may be concluded from these and other published data that ER may not be located at all times in a single subcellular compartment but may rather exist in a dynamic equilibrium between the plasma membrane, cytoplasm and nucleus.
Department of Biochemistry, Glaxo Research Laboratories, Research Triangle Park, NC 27709.
I
I
Parikh
K G
KG
Rajendran
J L
JL
Su
T
T
Lopez
M
M
Sar
D000911:Antibodies, Monoclonal / Q000276:immunology; D001692:Biological Transport; D001923:Brain Chemistry; D001943:Breast Neoplasms; D002467:Cell Nucleus / Q000032:analysis*; D003593:Cytoplasm / Q000032:analysis*; D003598:Cytoskeletal Proteins / Q000502:physiology; D005260:Female; D006801:Humans; D009376:Neoplasms, Hormone-Dependent / Q000032:analysis; D010902:Pituitary Gland / Q000032:analysis; D011959:Receptors, Estradiol / Q000032:analysis* / Q000276:immunology; D011960:Receptors, Estrogen / Q000032:analysis*; D011980:Receptors, Progesterone / Q000032:analysis; D014407:Tumor Cells, Cultured / Q000032:analysis; D014599:Uterus / Q000032:analysis
D000911:Antibodies, Monoclonal; D003598:Cytoskeletal Proteins; D011959:Receptors, Estradiol; D011960:Receptors, Estrogen; D011980:Receptors, Progesterone